International Biotechnology Trust PLC Amgen Inc Transaction History

International Biotechnology Trust PLC

$295 Million
Q3 2023

A detailed history of International Biotechnology Trust PLC transactions in Amgen Inc stock. As of the latest transaction made, International Biotechnology Trust PLC holds 79,246 shares of AMGN stock, worth $20.8 Million. This represents 7.23% of its overall portfolio holdings.

Number of Shares

79,246

Previous 117,246 32.41%

Holding current value

$20.8 Million

Previous $26 Million 18.18%

% of portfolio

7.23%

Previous 8.12%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $8.31 Million - $10.3 Million	-38,000 Reduced 32.41%	79,246 $21.3 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $5.57 Million - $6.59 Million	26,000 Added 28.49%	117,246 $26 Million
Q1 2023 May 18, 2023	BUY	$225.79 - $275.2 $16.9 Million - $20.6 Million	75,000 Added 461.65%	91,246 $22.1 Million
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $1.42 Million - $1.6 Million	6,331 Added 63.85%	16,246 $3.66 Million
Q2 2022 Aug 16, 2022	SELL	$230.71 - $256.74 $13.1 Million - $14.6 Million	-56,831 Reduced 85.15%	9,915 $40.7 Million
Q1 2022 May 20, 2022	SELL	$219.27 - $242.57 $17.1 Million - $18.9 Million	-78,000 Reduced 53.89%	66,746 $16.1 Million
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $5.26 Million - $6.02 Million	26,446 Added 22.36%	144,746 $32.6 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $14.3 Million - $16.7 Million	67,300 Added 131.96%	118,300 $25.1 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $1.87 Million - $2.07 Million	8,000 Added 18.6%	51,000 $12.4 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $6.44 Million - $7.5 Million	-29,000 Reduced 40.28%	43,000 $10.7 Million
Q4 2020 Feb 19, 2021	BUY	$216.38 - $257.67 $6.06 Million - $7.21 Million	28,000 Added 63.64%	72,000 $16.5 Million
Q3 2020 Dec 01, 2020	SELL	$234.65 - $260.95 $1.88 Million - $2.09 Million	-8,000 Reduced 15.38%	44,000 $11.2 Million
Q2 2020 Jul 14, 2020	SELL	$197.81 - $242.74 $2.77 Million - $3.4 Million	-14,000 Reduced 21.21%	52,000 $12 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $7 Million - $8.21 Million	42,000 Added 175.0%	66,000 $12.2 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $4.28 Million - $5 Million	24,000 New	24,000 $3.67 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $6.12 Million - $7.15 Million	-36,104 Closed	0 $0
Q3 2017 Mar 02, 2018	SELL	$167.29 - $191.0 $2.34 Million - $2.67 Million	-14,000 Reduced 27.94%	36,104 $6.73 Million
Q2 2017 Mar 02, 2018	SELL	N/A	-17,000 Reduced 25.33%	50,104 $8.63 Million
Q1 2017 Mar 02, 2018	SELL	N/A	-13,000 Reduced 16.23%	67,104 $11 Million
Q4 2016 Mar 02, 2018	BUY	N/A	80,104	80,104 $11.7 Million

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

407M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Account

International Biotechnology Trust PLC Amgen Inc Transaction History